Skip to content

Clinical trials

Leukemia, Myelomonocytic, Chronic trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Country / region: France Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20053
20071
20081
20092
20101
20121
20133
20142
20151
20162
20173
20184
20193
20204
20213
20234
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated7
Recruiting5
Active, not recruiting4
Unknown status2
Withdrawn2
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC6
Novartis Pharmaceuticals5
Groupe Francophone des Myelodysplasies4
Traws Pharma, Inc.3
Astex Pharmaceuticals, Inc.2
Centre Hospitalier Universitaire de Nice2
Janssen Research & Development, LLC2
Pfizer2
Taiho Oncology, Inc.2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic46
Myelodysplastic Syndromes34
Leukemia, Myeloid, Acute26
Leukemia10
Myeloproliferative Disorders9
Leukemia, Lymphocytic, Chronic, B-Cell6
Lymphoma, B-Cell, Marginal Zone6
Lymphoma, Large B-Cell, Diffuse6
Lymphoma, Mantle-Cell6
Primary Myelofibrosis6

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.